| A | B | |
|---|---|---|
1 | Notes on how to engage with our cost-effectiveness analysis | |
2 | ||
3 | Published: November 25, 2019 (original here) | |
4 | ||
5 | Azithromycin cost-effectiveness analysis last updated December 3, 2019 (moral weights updated January 27, 2021) | |
6 | This workbook contains our cost-effectiveness analysis. Estimates for a few parameters are included in the "Moral weights" tab. If you'd like to see how our results would change based on different inputs for these parameters, you can make a copy of this workbook and enter your own values in the "Anyone" column and select "Anyone" from the dropdown menu on that tab. Expanding the formula bar at the top of the page (by clicking and dragging the bottom boundary) may make it easier to read the contents of explanatory cells. | |
7 | ||
8 | ||
9 | Notes on color coding | |
10 | Blue text: direct input | |
11 | Green text: pulling from another cell in this workbook | |
12 | Black text: calculation | |
13 | ||
14 | Index | |
15 | User inputs | Allows staff members or anyone else to easily suppy their estimates for particularly uncertain parameters. |
16 | Moral weights | Allows staff members or anyone else to easily suppy numbers used to trade off different good outcomes. |
17 | Azithromycin | Cost-effectiveness analysis for mass distribution of azithromycin |
18 | Results | Shows cost-effectiveness estimates for each charity. |
28 | Inclusion/Exclusion | Used in the adjustment for excluded effects of our cost-effectivenes analyses. |
31 | ||
32 | Helpful GiveWell references | |
33 | Guide to GiveWell cost-effectiveness analyses | |
34 | Full reviews of our top charities | |
35 | Past versions of our cost-effectiveness analyses | |
36 | Discussion of cost-effectiveness as a criterion | |
37 | Blog posts discussing cost-effectiveness | |